Prosecution Insights
Last updated: May 29, 2026

The Trustees of Indiana University

20 pending office actions • 17 art units • 20 examiners • 0 of 20 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days

Portfolio Summary

20
Total Pending OAs
12
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
7
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (7)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
19
Medium (95%)
1
Easy (5%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only16 (80%)
§102 only3 (15%)
§112 only1 (5%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
10% of docket
2
Mechanical / Eng
10% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

200 h
Manual time on pending OAs
40 h
Time saved (low, 20%)
70 h
Time saved (mid, 35%)
1.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MORAN, EDWARD JOHN 1 41.4% +60.6%
BOND, REED MADISON 1 5.0% +25.0%
HA, NGUYEN Q 1 80.1% +4.2%
PLUMB, NIGEL H 1 90.6% +1.2%
ARCORIA, PAUL JOSEPH 1
HUMPHRIES, NICHOLAS ADAM 1 37.9% +77.5%
KOSTURKO, GEORGE W 1 54.2% +49.1%
BRAUN, MADELINE E 1 68.0% +24.9%
BOWLES, DAVID PAUL 1 75.0% +17.5%
MEYERING, SHABANA SHABBEER 1 71.2% +37.8%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18580854 METHODS AND SYSTEMS FOR RAPID DETECTION OF COVID-19 PLUMB, NIGEL H 32d overdue
18294443 METHODS OF TREATING COMPROMISED LUNG FUNCTION AND ASSESSING CLINICAL IMPROVEMENT HA, NGUYEN Q

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18769158 COMPUTER-IMPLEMENTED AI ASSISTANT, COMPUTER-IMPLEMENTED EDUCATIONAL PLATFORM, AND METHOD OF HIERARCHICALLY PROCESSING DATA BOND, REED MADISON 131d overdue

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18769158 COMPUTER-IMPLEMENTED AI ASSISTANT, COMPUTER-IMPLEMENTED EDUCATIONAL PLATFORM, AND METHOD OF HIERARCHICALLY PROCESSING DATA BOND, REED MADISON 131d overdue
18262799 PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE HUMPHRIES, NICHOLAS ADAM 8d overdue
18258673 METHODS TO SENSITIZE CANCER CELLS AND STANDARDIZED SCREENING ASSAY FOR IMMUNOTHERAPY BRAUN, MADELINE E 8d overdue
18027476 FOXP3S-PROMOTING MORPHOLINOS MEYERING, SHABANA SHABBEER 5d overdue
18260115 TOCOTRIENOL COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC STEATOHEPATITIS KOSTURKO, GEORGE W 14d
18033229 MOLECULAR DESIGNS OF GLUCOSE-RESPONSIVE AND GLUCOSE-CLEAVABLE INSULIN ANALOGUES BOWLES, DAVID PAUL 28d
18913249 DENTAL IMPLANTS, DENTAL ASSEMBLIES, AND METHODS OF IMPLANTING AND REPAIRING DENTAL ASSEMBLIES MORAN, EDWARD JOHN 33d

Top Art Units

Art UnitApps
1621 2
1635 2
1653 2
3772 1
3624 1
2853 1
2855 1
1631 1
1624 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18913249 DENTAL IMPLANTS, DENTAL ASSEMBLIES, AND METHODS OF IMPLANTING AND REPAIRING DENTAL ASSEMBLIES MORAN, EDWARD JOHN 3772 §103 Non-Final OA 33d Pending Oct 11, 2024
18769158 COMPUTER-IMPLEMENTED AI ASSISTANT, COMPUTER-IMPLEMENTED EDUCATIONAL PLATFORM, AND METHOD OF HIERARCHICALLY PROCESSING DATA BOND, REED MADISON 3624 §103 Non-Final OA 131d overdue Pending Jul 10, 2024
18294443 METHODS OF TREATING COMPROMISED LUNG FUNCTION AND ASSESSING CLINICAL IMPROVEMENT HA, NGUYEN Q 2853 §103 Final Rejection Pending Feb 01, 2024
18580854 METHODS AND SYSTEMS FOR RAPID DETECTION OF COVID-19 PLUMB, NIGEL H 2855 §103 Non-Final OA 32d overdue Pending Jan 19, 2024
18541121 POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR ARCORIA, PAUL JOSEPH 1621 §103 Non-Final OA 28d Pending Dec 15, 2023
18262799 PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE HUMPHRIES, NICHOLAS ADAM 1631 §103 Non-Final OA 8d overdue Pending Jul 25, 2023
18260115 TOCOTRIENOL COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC STEATOHEPATITIS KOSTURKO, GEORGE W 1621 §103 Final Rejection 14d Pending Jun 30, 2023
18258673 METHODS TO SENSITIZE CANCER CELLS AND STANDARDIZED SCREENING ASSAY FOR IMMUNOTHERAPY BRAUN, MADELINE E 1624 §102 Non-Final OA 8d overdue Pending Jun 21, 2023
18033229 MOLECULAR DESIGNS OF GLUCOSE-RESPONSIVE AND GLUCOSE-CLEAVABLE INSULIN ANALOGUES BOWLES, DAVID PAUL 1654 §103 Non-Final OA 28d Pending Apr 21, 2023
18027476 FOXP3S-PROMOTING MORPHOLINOS MEYERING, SHABANA SHABBEER 1635 §103 Non-Final OA 5d overdue Pending Mar 21, 2023
18042931 METHODS TO PREVENT HIGH-GRADE SEROUS OVARIAN CANCER AND BREAST CANCER BY ADMINISTERING ANTIPROGESTINS GAUGER, PAUL RANDALL 1629 §103 Non-Final OA 37d overdue Pending Feb 24, 2023
18041241 QUORUM SENSING INHIBITORS AND METHODS OF USE OTTON, ALICIA L 1699 §102 Final Rejection Pending Feb 10, 2023
18040834 IN VIVO LYMPHOVENOUS ANASTOMOSIS SHIN, DANA H 1635 §103 Final Rejection 9d Pending Feb 07, 2023
17960968 MXENES-METAL AND CERAMIC ASSEMBLIES AND COMPOSITES ABU ALI, SHUANGYI 1731 §103 Final Rejection 17d overdue Pending Oct 06, 2022
17913189 IMMUNOTHERAPEUTIC TARGETS IN MULTIPLE MYELOMA AND METHODS FOR THEIR IDENTIFICATION BUNKER, AMY M 1684 §102 Non-Final OA 26d Pending Sep 21, 2022
17870785 N-PROPANOL/H2O MIXED SOLVENT COMPOSITIONS FOR MEMBRANE ELECTRODE ASSEMBLIES LYNCH, VICTORIA HOM 1724 §103 Final Rejection 163d overdue Pending Jul 21, 2022
17791981 SYSTEM AND METHOD FOR PROCESSING VIRUS PREPARATIONS TO REDUCE HETEROGENEITY SIFFORD, JEFFREY MARK 1671 §103 Non-Final OA 16d Pending Jul 11, 2022
17770183 COMPOSITIONS AND METHODS FOR ENHANCING RETINAL GANGLION CELL DEVELOPMENT AND PLURIPOTENT STEM CELL-DERIVED THREE-DIMENSIONAL TISSUE TICHY, JENNIFER M.H. 1653 §103 Final Rejection 88d overdue Pending Apr 19, 2022
17761121 PROLONGED FUNCTION OF LIVER ORGANOIDS BY 3D COCULTURING OF HEPATIC LINAGE CELLS AS AN IN VITRO MODEL FOR THE STUDY OF LIVER DISEASE BARRON, SEAN C 1653 §103 Final Rejection 30d overdue Pending Mar 16, 2022
17639263 VASCULOGENIC FIBROBLASTS CHONG, KIMBERLY 1636 §112 Non-Final OA 27d Pending Feb 28, 2022

Managing The Trustees of Indiana University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month